HWM
BBIO icon

Hemington Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Hemington Wealth Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11K Buy
229
+70
+44% +$3.41K ﹤0.01% 837
2025
Q2 		$6K Buy
159
+37
+30% +$1.35K ﹤0.01% 1022
2025
Q1 		$4K Buy
122
+76
+165% +$2.56K ﹤0.01% 1094
2024
Q4 		$1K Buy
46
+11
+31% +$284 ﹤0.01% 1367
2024
Q3 		$0 Buy
+35
New +$919 ﹤0.01% 1496

Other funds holding BBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hemington Wealth Management's BBIO Position: Q3 2025 in Review

Hemington Wealth Management increased its BridgeBio Pharma (BBIO) stake by 44% in Q3 2025, buying an estimated $3.41K and bringing the position to 229 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Hemington Wealth Management first reported a position in BBIO in Q3 2024 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold BBIO as of Q3 2025.

  • Hemington Wealth Management held 229 shares of BridgeBio Pharma worth $11K as of Q3 2025.
  • Hemington Wealth Management bought 70 BridgeBio Pharma shares in Q3 2025, an estimated $3.41K.
  • BridgeBio Pharma made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #837 holding.
  • Hemington Wealth Management first reported a position in BridgeBio Pharma in Q3 2024 and has held it in 5 quarters since.
  • 392 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.